Sexually transmissible agent and African Kaposi's sarcoma [editorial] NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Sexually transmissible agent and African Kaposi's sarcoma [editorial]

Int J STD AIDS. 1996 Jan-Feb;7(1):4-6. Unique Identifier : AIDSLINE MED/96228417
Matondo P; Sivapalan S

Abstract: Kaposi's sarcoma (KS) has a higher incidence in some parts of Africa than anywhere else in the world. Recent studies in western homosexual men with AIDS-KS suggest that KS may be caused by a putative sexually transmissible agent. Our analytical review of studies on KS in Africa before and during the AIDS era reveals a disparate epidemiological picture. Its occurrence in sexually inexperienced children; overwhelming male preponderance in an almost exclusively heterosexual population; rarity of concordant couples in areas of very high incidence; sequestration of high incidence to Eastern and Central Africa; and regional variations in incidence even in high-incidence countries are all difficult to reconcile with a conventional sexually transmissible aetiology. There is a need for prospective studies specifically designed to test the hypothesis in Africa. Also, we recommend that studies pursuing the aetiology of KS in western countries be linked with studies in high incidence areas in Africa.
Keywords: Adult Africa/EPIDEMIOLOGY AIDS-Related Opportunistic Infections/EPIDEMIOLOGY/*TRANSMISSION Child Female Human Incidence Male *Sarcoma, Kaposi's/EPIDEMIOLOGY Sex Behavior Sexually Transmitted Diseases/EPIDEMIOLOGY/*TRANSMISSION EDITORIAL REVIEW REVIEW, TUTORIAL JOURNAL ARTICLEKWDadultafrica/epidemiologyaids-relatedopportunisticinfections/epidemiology/KWDtransmissionchildfemalehumanincidencemaleKWDsarcoma,kaposi's/epidemiologysexbehaviorsexuallytransmitteddiseases/epidemiology/KWDtransmissioneditorialreviewreview,tutorialjournalarticle
961030
M96A1435

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .